EA therapy for CCH with hypertension may be mediated via downregulation of the hippocampal ACE/Ang II/AT1R axis and upregulation of the hippocampal ACE2/Ang-(1-7)/MasR axis. This evidence concerns the gene ACE2 and Hypertension.